Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 14.49%

Quest Diagnostics Incorporated EBIT Margin is 14.49% for the Trailing 12 Months (TTM) ending June 30, 2025, a 4.28% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 13.90%, a 9.62% change year over year.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 12.68%, a -35.49% change year over year.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 19.66%, a -30.16% change year over year.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 28.14%, a 85.26% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin